Artificial intelligence (AI) is a major branch of computer science that is fruitfully used for
analyzing complex medical data and extracting meaningful relationships in datasets, for …

Parkinson's disease (PD) is the second most common neurodegenerative disease bearing a
severe social and economic impact. So far, there is no known disease modifying therapy …

The use of Artificial Intelligence and machine learning in basic research and clinical
neuroscience is increasing. AI methods enable the interpretation of large multimodal …

Normative databases allow testing of novel hypotheses without the costly collection of
magnetic resonance imaging (MRI) data. Here we present the Amsterdam Ultra-high field …

Advances in computational neuroimaging techniques have expanded the armamentarium of
imaging tools available for clinical applications in clinical neuroscience. Non-invasive, in …

Objective Subthalamic deep brain stimulation (DBS) is an established therapy for
Parkinson's disease. Connectomic DBS modeling is a burgeoning subfield of research …

The first commercially available 7-T MRI scanner (Magnetom Terra) was approved by the
FDA in 2017 for clinical imaging of the brain and knee. After initial protocol development and …

Background Subthalamic nucleus (STN) deep brain stimulation (DBS) is regarded as an
effective treatment for patients with advanced Parkinson's disease (PD). Clinical benefit …

Abstract Purpose of Review Deep brain stimulation (DBS) is an established treatment in
several movement disorders, including Parkinson's disease, dystonia, tremor, and Tourette …

Deep brain stimulation (DBS) is a surgical treatment for advanced Parkinson's disease (PD)
that has undergone technological evolution that parallels an expansion in clinical …